China investigating 'fatal' herbal injection

China's State Food and Drug Administration (SFDA) are scrutinizing a drug, named Shuanghuanglian, which is the product of Duoduo Pharmaceutcal Company, Ltd. in Heilongjiang. The drug regulators are suspicious that this herbal injection might be the reason behind three deaths that occurred in three different provinces of country. 

SFDA, in association with China's Ministry of health, has deputed an investigation team to probe this case.

Until the reality comes to the fore, the sale and the distribution of the controversial drug have been suspended. Druggists and hospitals also have been advised to hold back the use of this injection till the investigation gives its report.

Earlier in the year also, shuanghuanglian had reportedly caused unfavorable effect on three patients. One patient, out of the three, met death later.